RE:Deals Done?I hope your wrong Goldtech, but nothing would surprize me. The companies comments in its quarterly reports is getting so old i cant remember how far back ? maybe two years..
August 2013, "Finally, we are in business discussions with a number of leading pharmaceutical companies for platform technology deals and partnerships as well as licensing deals for our Alzheimer's disease diagnostic test and our cancer therapeutic antibody projects "
If we see another private placement and the insiders are in it, I am going to be protesting to the OSC they approve it. Why would the board want to make a deal if the Insiders can keep giving them selves PP, especially at this price. They will scoop the company with share dilution and please don't anyone make excuses about them going broke...back in the earlier days Amorfix signed a research and investment agreement with Biogen for shares priced at $1.46, in my view they probally could have done other agreements like this but that would have taken away PP's to insiders.There are other methods of financing but why would the insiders want to if they can keep participating in PP's. Black, Cashman and Gundel have financially engineered this Company to 8 cents, while many of them accumulating millions of shares over the last 5 years, increasing their stock option plan from 7,000,000 to 12,000,000 last fall, not giving a rats hoot about the majority of investors in Amorfix.